4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-25-120155
SrVP/CFO/Prin Fin & Acct Ofcr bought 5,000 shares at $1.17 ($5,825)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2025-12-10 | Purchase | +5,000 | $1.17 | $5,825 | 27,733 | D |
| Derivatives | |||||||
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2025-12-10 | Purchase · Common Warrant | +5,000 | 5,000 | D | ||
| Open-market purchases · 5,000 sh · avg $1.17 · $5,825 | |||||||
Loading xslF345X05/tm2533219-2_4seq1.xml…